Edmond de Rothschild Private Equity

Type

Private equity

Status

Active

Location

Geneva, Switzerland

Total investments

17

Average round size

44M

Portfolio companies

15

Rounds per year

0.24

Lead investments

2

Follow on index

0.12

Exits

8

Stages of investment
Private Equity
Areas of investment
BiotechnologyHealth CareMedicalPharmaceuticalTherapeuticsEnergyBiopharmaOil and GasMiningEnergy Management

Summary

In 1953 was created Edmond de Rothschild Private Equity, which is appeared as VC. The leading representative office of defined VC is situated in the Paris. The company was established in Europe in France.

We also calculated 6 valuable employees in our database.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Edmond de Rothschild Private Equity, startups are often financed by Index Ventures, MP Healthcare Venture Management, Andera Partners. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Index Ventures, Forbion Capital Partners. In the next rounds fund is usually obtained by Nicholas Benedict, Forbion Capital Partners, EMBL Ventures.

Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2013. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Edmond de Rothschild Private Equity performs on 54 percentage points more the average number of lead investments. The top amount of exits for fund were in 2014.

Among the various public portfolio startups of the fund, we may underline Genkyotex, Covagen, Allecra Therapeutics For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. We can highlight the next thriving fund investment areas, such as Children, Biotechnology. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Show more

Investor highlights

Stage focus
Pre-SeedSeedSeries ASeries BSeries C

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
17
Lead investments
2
Exits
8
Rounds per year
0.24
Follow on index
0.12
Investments by industry
  • Biotechnology (9)
  • Pharmaceutical (6)
  • Biopharma (4)
  • Health Care (4)
  • Medical (3)
  • Show 15 more
Investments by region
  • United Kingdom (2)
  • France (4)
  • Switzerland (4)
  • United States (3)
  • Germany (3)
  • Show 1 more
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
25
Avg. valuation at time of investment
52M
Group Appearance index
0.82
Avg. company exit year
10
Avg. multiplicator
2.11

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Swiss Summit Capital 05 Apr 2019 Financial Services Early Stage Venture 25M England, London, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.